Diggelmann Roland (Roland Diggelmann)

Diggelmann Roland (Roland Diggelmann)

Biography

Since 2008 worked in the Swiss company Roche. At first was the regional manager of the company in the Pacific Rim.

Since 2012 passed into department of diagnostics of Roche Diagnostics.

For August 30, 2018 was a head of department of Roche Diagnostics as a part of Roche company.

At the end of September, 2018 Roland Diggelmann will leave Roche Diagnostics post of the head. The exact reason of resignation in Roche was not stated, having limited to an indistinct explanation of intention of Diggelmann "continue career outside the company".^[1]

2019: Appointment of Smith & Nephew as the CEO

At the end of October, 2019 the Smith & Nephew company which is engaged in development and sale of the iatrotechnics announced that since November 1 Roland Diggelmann will become the new CEO.

Diggelmann who was earlier heading diagnostic division of Roche within the last one and a half years, i.e. since March, 2018 is the board member of Smith & Nephew. It is known that Diggelmann within 12 years worked in orthopedic department of Zimmer Biomet and also in Sulzer Orthopedics. Then he headed Roche Diagnostics, subsidiary company of the Swiss medical producer Roche with an annual turnover in $11.5 billion where he worked for six years up to 2018. Diggelman is a citizen of Switzerland and lives in Baar.

The Smith & Nephew company announced that since November 1 Roland Diggelmann will become the new CEO

It is known that offered Diggelmann the CEO's position in October, 2017, but he could not join the company. So far do not expect any serious changes in the development strategy from the new director, and it is supposed that many shareholders, "most likely, will assess him positively".

The acting CEO Namal Nawana who worked in this position of 18 months resigns on October 31, but will remain in company management until the end of the year that "provide council and support" to the successor. It is supposed that Nawana who got used to work with the American producers of the medical equipment the British standards of payment of a position of the chief executive did not arrange.

According to analysts, many investors of Smith & Nephew company, especially in Great Britain, will welcome his successor and will approve the solution of Board of Directors to limit salary to upper managers.^[2]

Notes